Young Hun Chung

University of California, San Diego — United States

Medicine · Health Sciences

11h-index1.7kcitations29works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral gastroenteritis research and epidemiology(7), Bacteriophages and microbial interactions(7), SARS-CoV-2 and COVID-19 Research(5), Plant Virus Research Studies(4), Immunotherapy and Immune Responses(4)

Publications29 total

Metastatic Melanoma Treatment and Prophylaxis with S100A9-Targeting Cowpea Mosaic Virus Nanoparticles
Methods in molecular biology·2025
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Small Science·2024· 2 citedOpen Access
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Small Science·2024· 2 citedOpen Access
Abstract 497: Plant viruses against cancer
Cancer Research·2024
Systemic Administration of Cowpea Mosaic Virus Demonstrates Broad Protection Against Metastatic Cancers
Advanced Science·2024· 11 citedOpen Access
Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus
Materials Advances·2024· 5 citedOpen Access
Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis
Proceedings of the National Academy of Sciences·2023· 25 citedOpen Access
TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy
Bioconjugate Chemistry·2023· 16 citedOpen Access
The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA
Molecular Pharmaceutics·2023· 7 citedOpen Access
Development of a Modular NTA:His Tag Viral Vaccine for Co-delivery of Antigen and Adjuvant
Bioconjugate Chemistry·2023· 11 citedOpen Access
A co-formulated vaccine of irradiated cancer cells and cowpea mosaic virus improves ovarian cancer rejection
Journal of Materials Chemistry B·2023· 9 citedOpen Access
Instigation of the epoch of nanovaccines in cancer immunotherapy
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology·2022· 12 citedOpen Access
Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles
Biomacromolecules·2022· 6 citedOpen Access
Polynorbornene-based bioconjugates by aqueous grafting-from ring-opening metathesis polymerization reduce protein immunogenicity
Cell Reports Physical Science·2022· 8 citedOpen Access
Abstract 297: Prophylaxis and treatment of metastatic breast cancer and melanoma using S100A9-targeted cowpea mosaic virus nanoparticles
Cancer Research·2022
Integrating plant molecular farming and materials research for next-generation vaccines
Nature Reviews Materials·2021· 138 citedOpen Access
S100A9‐Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma
Advanced Science·2021· 41 citedOpen Access
The <i>in vivo</i> fate of tobacco mosaic virus nanoparticle theranostic agents modified by the addition of a polydopamine coat
Biomaterials Science·2021· 13 citedOpen Access
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
ACS Nano·2020· 338 citedOpen Access
COVID-19 vaccine development and a potential nanomaterial path forward
Nature Nanotechnology·2020· 667 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Nicole F. Steinmetz(21), Eunkyeong Jung(6), Zhongchao Zhao(5), Sourabh Shukla(3), Oscar A. Ortega‐Rivera(3), Jonathan K. Pokorski(3), Britney A. Volckaert(3), Veronique Beiss(2), Hui Cai(2), Steven Fiering(2), Derek C. Church(2), Jooneon Park(2), Anahid Foroughishafiei(2), Matthew D. Shin(1), Soo Khim Chan(1), David M. Wirth(1), Angela Chen(1), M. Sack(1), Edward C. Koellhoffer(1), Elizabeth O. Osota(1)